Motif

Motif

Private
Houston, TexasHealthcare & Life Scienceshttps://www.motifneuro.tech

Last Round

Grant

Jan 20, 2025

Total Funding Raised

$24.75M

Company Overview

Motif (Therapeutic Devices) is a biotechnology company that develops bioelectronic systems for treating treatment-resistant depression through innovative wireless power and data technologies, facilitating minimally invasive electronic therapies for neural circuit repair.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Mental Health, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

brain-computer interfaceBCIneuromodulationtreatment-resistant depressionTRDneural implantbrain implantbrain chipneurostimulationimplantable medical devicebrain stimulationminimally invasive implantbioelectronicsimplantable brain pacemakerat-home therapybattery-free implantmental health treatmentwireless power transfermajor depressive disorderMDD

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Motif Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Motif Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJan 20, 2025
Series AJan 24, 2024
AcceleratorFeb 27, 2023

Key People

Founding team and executive leadership

Jacob Robinson

Co-Founder And CEO

Founding Team

Steven Goetz

Chief Technology Officer

Executive Team

Nick Halper

Chief Operating Officer

Executive Team

Motif Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 14, 2025

    Developing a neurostimulator system for severe depression treatment.

  • Jan 20, 2025

    Secured $6M in grant funding.

Motif Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Motif Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Motif's valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas
Employee Range33
Year Founded2022
Last FundingJan 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.